BiologicsSports Medicine

Stryker and AlloSource announce collaboration to distribute biologics for use in sports medicine procedures

DENVER, May 18, 2017 /PRNewswire-USNewswire/ — Today at the 2017 Annual Arthroscopy Association of North America (AANA) Meeting (booth #109), Stryker’s Sports Medicine business and AlloSource® formally announced their collaboration to provide high quality, innovative biologics for use in sports medicine procedures. This collaboration is driven by the companies’ combined commitment to better serve their customers, help patients in need and fully honor the gift of tissue donation.

“We believe biologics will play a critical role in advancing the field of Sports Medicine, so we are very excited about the opportunity to collaborate with AlloSource given their history of quality and innovation,” said Matt Moreau, Vice President & General Manager of Stryker’s Sports Medicine business. “The collaboration between Stryker and AlloSource will enable us to combine our unique areas of expertise to develop new ways to improve patient outcomes.”

Through the collaboration, Stryker’s Sports Medicine nationwide sales force will distribute AlloSource biologics for use in a variety of sports medicine procedures.

“Deepening our relationship with Stryker through this sports medicine collaboration will help us further advance patient healing and honor our tissue donors by getting biologics in the hands of more surgeons,” said Kerr Holbrook, AlloSource Chief Commercial Officer. “We look forward to working and growing together.”

For more information, please visit Stryker’s website or AlloSource’s website.

About Stryker
Stryker is one of the world’s leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world. Please contact us for more information at

About AlloSource
AlloSource is one of the largest nonprofit cellular and tissue networks in the country, offering more than 200 types of precise cartilage, cellular, bone, skin and soft-tissue allografts to advance patient healing. For more than 20 years, AlloSource’s products have bridged the proven science of allografts with the advanced technology of cells, offering life-saving and life-enhancing possibilities in spine, sports medicine, foot and ankle, orthopedic, reconstructive, trauma and wound care procedures. As the world’s largest processor of cellular bone allografts, fresh cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource delivers unparalleled expertise and service to its growing network of surgeons, partners, and the country’s most reputable organ procurement organizations. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit or our educational website,

Media contacts
Jon Zimmer, Stryker,
Megan Duggan, AlloSource,


SOURCE AlloSource

Related Links

Print Friendly, PDF & Email

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button